Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLargo, Inc. (BLGO) had Revenue of $17.78M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$17.78M
Net Income	$-2.40M
Cost of Goods Sold	$9.93M
Gross Profit	$7.85M
Operating Expenses	$22.11M
Operating Income	$-4.33M
Non-Operating Income/Expense	$-0.02M
Pre-Tax Income	$-4.35M
Normalized Pre-Tax Income	$-4.35M
Income after Taxes	$-4.35M
Income from Continuous Operations	$-4.35M
Consolidated Net Income/Loss	$-4.35M
Normalized Income after Taxes	$-4.35M
EBIT	$-4.33M
EBITDA	$-4.08M
Weighted-Average Shares Outstanding (Basic)	298.12M
Weighted-Average Shares Outstanding (Diluted)	298.12M
Earnings per Share (EPS) (Basic)	$-0.01
Earnings per Share (EPS) (Diluted)	$-0.01
Balance Sheet Financials
Current Assets	$7.14M
Property, Plant, and Equipment	$1.74M
Long-Term Assets	$3.38M
Total Assets	$10.51M
Current Liabilities	$2.65M
Long-Term Debt	$0.89M
Long-Term Liabilities	$1.81M
Total Liabilities	$4.46M
Common Equity	$6.06M
Tangible Shareholders Equity	$6.06M
Shareholders Equity	$6.06M
Common Shares Outstanding	301.27M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-3.21M
Cash Flow from Investing Activities	$-1.32M
Cash Flow from Financial Activities	$4.44M
Beginning Cash	$3.54M
End Cash	$3.55M
Increase/Decrease in Cash	$0.01M
Stock-Based Compensation	$2.48M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.70
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.13
Debt to Equity Ratio	0.25
Gross Margin	44.17%
Operating Margin	-24.36%
EBIT Margin	-24.36%
EBITDA Margin	-22.93%
Pre-Tax Profit Margin	-24.45%
Profit Margin	-13.51%
Free Cash Flow	$-4.44M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.69
Inventory Turnover	30.08
Receiveable Turnover	5.61
Days Sales in Receivables	65.04
Return on Equity	-71.78%
Return on Tangible Equity	-71.78%
Return on Assets	-41.35%
Return on Investments	-62.61%
Book Value Per Share	$0.02
Free Cash Flow per Share	$-0.01
Operating Cash Flow per Share	$-0.01

Data from Zacks Investment Research, Inc.